Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-253272
Filing Date
2024-11-07
Accepted
2024-11-07 16:58:37
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d899727ds3.htm S-3 330973
2 EX-1.2 d899727dex12.htm EX-1.2 183839
3 EX-5.1 d899727dex51.htm EX-5.1 31487
4 EX-23.2 d899727dex232.htm EX-23.2 1302
5 EX-FILING FEES d899727dexfilingfees.htm EX-FILING FEES 52964
6 GRAPHIC g899727dsp33.jpg GRAPHIC 1554
7 GRAPHIC g899727dsp34.jpg GRAPHIC 1212
8 GRAPHIC g899727g57f20.jpg GRAPHIC 35163
  Complete submission text file 0001193125-24-253272.txt   654276
Mailing Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110
Business Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)

EIN.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-283073 | Film No.: 241436856
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)